Cited 0 time in
Modulation of ATP level and PARP activity alters mode of neuronal cell death and shows anti-edema effect in the model of ischemic/reperfusion injury.
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 김승현 | - |
| dc.date.accessioned | 2021-08-04T06:39:47Z | - |
| dc.date.available | 2021-08-04T06:39:47Z | - |
| dc.date.issued | 2003-10-24 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/75842 | - |
| dc.description.abstract | Cellular energy status may be important in determining the mode of cell death induced by an oxidative stress and ischemic injury. Overactivation of nuclear enzyme poly(ADP-ribose) polymerase (PARP) causes dramatic ATP consumption and has an important role in necrotic cellular death mechanism. The present study was conducted to evaluate the effect of PARP inhibitor (3-AB) and NAD on ischemic cellular death mechanisms and ischemic volume in the rat MCA stroke model. Compared with non-treated group, the volume of infarction was decreased about 34% in 3-AB treated group, and 45% in 3-AB plus NAD treated group. Compared with non-treated group, in both groups, immunoreactivities of PAR and COX-2 were significantly reduced in ischemic regions. However, those of activated caspase-3 were significantly increased. These findings were more significant in 3-AB plus NAD group | - |
| dc.title | Modulation of ATP level and PARP activity alters mode of neuronal cell death and shows anti-edema effect in the model of ischemic/reperfusion injury. | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | 대한신경과학회 추계학술대회 | - |
| dc.citation.conferencePlace | 서울교육문화회관 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
